Evidence map›Paper›PMID 42550247›Full record

ArticleRheumatology international2026

Relation of nailfold capillaries and autoantibodies to mortality in patients with Raynaud's phenomenon: a retrospective analysis.

Markus Müller, Michael E Gschwandtner, Hans Kiener, Thomas Perkmann, Sonja Zehetmayer, Sophie Brunner-Ziegler, Sabine Steiner, Oliver Schlager

Abstract read
In one paragraph

Article in Rheumatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Markus MüllerDivision of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria. markus.a.mueller@meduniwien.ac.at.ORCID http://orcid.org/0000-0003-1350-3742
Michael E GschwandtnerDivision of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.
Hans KienerDivision of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-5391-1954
Thomas PerkmannDepartment of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-7976-0285
Sonja ZehetmayerCenter for Medical Data Science, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-6863-7997
Sophie Brunner-ZieglerDivision of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-7825-1254
Sabine SteinerDivision of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-5680-1072
Oliver SchlagerDivision of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-6934-5355

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of abnormal nailfold capillaries and antinuclear antibodies (ANA) is associated with increased all-cause mortality in patients presenting with incipient Raynaud's phenomenon (RP). We conducted a retrospective analysis aiming to assess the association between abnormal nailfold capillaries, ANA, and mortality over a 20-year follow-up period. In 2958 patients with incipient RP without previously known connective tissue disease, nailfold capillaroscopies and laboratory tests for ANA and ANA-subsets were obtained. Of these, long-term follow-up data were available for 2922 patients. Over a median follow-up period of 23 (IQR 20.2-25.2) years, 832 patients died, of which 562 were women (25% of female patients) and 270 were men (41% of male patients). Compared to a demographically matched reference population, mortality was increased in female and male patients with RP (log-rank test < 0.001). In female patients with RP, the presence of ANA, anti-Scl-70 antibodies, and a grouping variable consisting of giant capillaries, reduced capillary density, and avascular fields was associated with an increase in all-cause mortality. The highest mortality was observed in patients presenting both abnormal nailfold capillaries and ANA. In the long-term, an excess mortality persists in patients with RP. Our study demonstrates prognostic associations between abnormal nailfold capillaries as well as ANA and mortality.

Indexed as

Antibodies, AntinuclearCapillariesNailsRaynaud DiseaseAdultAgedFemaleHumansMaleMicroscopic AngioscopyMiddle AgedRetrospective StudiesAntibodies, AntinuclearMicrovascular dysfunctionMortalityNailfold capillaroscopyRaynaud phenomenonSmall-vessel disease

Identifiers

PMID42550247
PMCPMC13437655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.